Trading Signals: ADAP Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Fri. May. 28, 2021)(Adaptimmune Therapeutics plc)
| ADAP latest price $5.7400 (-1.71%) ($5.6600 - $5.9600) on Fri. Jan. 11, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.72% (three month average) | RSI | 76 | Latest Price | $5.7400(-1.71%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ADAP advances 15.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ADAP advance at 0% a week (0% probability) EMHY(12%) PCY(11%) CEMB(9%) HYG(7%) JNK(7%) | Factors Impacting ADAP price | ADAP will decline at least -3.36% in a week (0% probabilities). XOP(-12%) USO(-12%) IFRA(-8%) SLV(-7%) XME(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.36% (StdDev 6.72%) | Hourly BBV | 0 () | Intraday Trend | -1.9% | | | |
|
5 Day Moving Average | $5.85(-1.88%) | 10 Day Moving Average | $5.69(0.88%) | 20 Day Moving Average | $5.11(12.33%) | To recent high | -54.5% | To recent low | 12.3% | Market Cap | $887m | | | | Adaptimmune Therapeutics Plc engages in the development of novel cancer immunotherapy products. Its specific peptide enhanced affinity receptor platform enables the engineering of T-cells to target and destroy cancer, including solid tumors. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom. |